Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass
Authors:
- Bechara F. AklBABechara F. Akl
- G.M. VargasGVG.M. Vargas
- J. NealJNJ. Neal
- J. RobillardJRJ. Robillard
- P. KellyPKP. Kelly
- 1 January 1980
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 79 (1) , 97-102
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Adequate Anticoagulation During Cardiopulmonary Bypass Determined by Activated Clotting Time and the Appearance of Fibrin MonomerThe Annals of Thoracic Surgery, 1978
- Control of Heparinization by Activated Clotting Time During Bypass with Improved Postoperative HemostasisThe Annals of Thoracic Surgery, 1977
- Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgeryThe Journal of Thoracic and Cardiovascular Surgery, 1977
- Hemotensiometry: A New Technique for the Study of Hemostasis in Open-Heart SurgeryThe Annals of Thoracic Surgery, 1974
- A Simple Method of Heparin Management During Prolonged Extracorporeal CirculationThe Annals of Thoracic Surgery, 1974
- Monitoring Heparin Therapy in Hemodialysis1973
- Statistical Correlation and Heparin Sensitivity of Activated Partial Thromboplastin Time, Whole Blood Coagulation Time, and an Automated Coagulation TimeAmerican Journal of Clinical Pathology, 1973
- Protamine sulfate administration and the cardiovascular systemThe Journal of Thoracic and Cardiovascular Surgery, 1971
- Cardiovascular Effects of Protamine SulfateThe Annals of Thoracic Surgery, 1969
- Activated Coagulation Time of Whole BloodJAMA, 1966